S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed
Protocol For Assessment Of Capecitabine For Advanced Colorectal Cancer In Patients Aged 70 Years And Older (And In A Cohort Of Patients Younger Than 60 Years)
3 other identifiers
interventional
29
1 country
90
Brief Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of capecitabine in treating older patients who have metastatic or recurrent colorectal cancer that cannot be surgically removed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2 colorectal-cancer
Started Feb 2003
Typical duration for phase_2 colorectal-cancer
90 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 12, 2002
CompletedFirst Posted
Study publicly available on registry
January 27, 2003
CompletedStudy Start
First participant enrolled
February 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2007
CompletedJanuary 3, 2013
January 1, 2013
4.3 years
November 12, 2002
January 2, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of enrolling patients aged 70 years or older to a Phase II trial including pharmacokinetic sampling
Registration
Secondary Outcomes (5)
Efficacy of capecitabine for management of advanced colorectal cancer patients aged 70 years or older based on objective response rate and 2 year survival
2 years
Toxicity
3 years
Assess parameters of clinical pharmacology of capecitabine in patients aged 70 years or older including half life value(s), AUC (area under curve) and steady state levels
3 years
Assess whether patients under 60 years have clinical pharmacologic parameters similar to those reported in the literature
3 years
Explore, at a preliminary level, the feasibility of studying genetic polymorphisms and gene expression levels of enzymes involved in drug metabolism and resistance to capecitabine
3 years
Study Arms (1)
Capecitabine
EXPERIMENTALCapecitabine 1,000 mg/m\^2/dose (2,000 mg/m\^2/day) BID, PO, Days 1-14 of 21 day cycle.
Interventions
1,000 mg/m\^2/dose (2,000 mg/m\^2/day) BID, PO, on Days 1-14 of 21 day cycle
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- SWOG Cancer Research Networklead
- National Cancer Institute (NCI)collaborator
Study Sites (90)
MBCCOP - Gulf Coast
Mobile, Alabama, 36607, United States
CCOP - Western Regional, Arizona
Phoenix, Arizona, 85006-2726, United States
Veterans Affairs Medical Center - Phoenix (Carl T. Hayden)
Phoenix, Arizona, 85012, United States
Veterans Affairs Medical Center - Tucson
Tucson, Arizona, 85723, United States
Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, 85724, United States
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
Veterans Affairs Medical Center - Little Rock
Little Rock, Arkansas, 72205, United States
City of Hope Comprehensive Cancer Center
Duarte, California, 91010-3000, United States
Veterans Affairs Medical Center - Loma Linda (Pettis)
Loma Linda, California, 92357, United States
USC/Norris Comprehensive Cancer Center and Hospital
Los Angeles, California, 90033, United States
Jonsson Comprehensive Cancer Center, UCLA
Los Angeles, California, 90095-1781, United States
Veterans Affairs Outpatient Clinic - Martinez
Martinez, California, 94553, United States
CCOP - Bay Area Tumor Institute
Oakland, California, 94609-3305, United States
Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center
Orange, California, 92868, United States
University of California Davis Cancer Center
Sacramento, California, 95817, United States
CCOP - Santa Rosa Memorial Hospital
Santa Rosa, California, 95403, United States
University of Colorado Cancer Center at University of Colorado Health Sciences Center
Aurora, Colorado, 80010, United States
Veterans Affairs Medical Center - Denver
Denver, Colorado, 80220, United States
MBCCOP - Howard University Cancer Center
Washington D.C., District of Columbia, 20060, United States
Veterans Affairs Medical Center - Tampa (Haley)
Tampa, Florida, 33612, United States
CCOP - Atlanta Regional
Atlanta, Georgia, 30342-1701, United States
MBCCOP - Hawaii
Honolulu, Hawaii, 96813, United States
MBCCOP - University of Illinois at Chicago
Chicago, Illinois, 60612, United States
Veterans Affairs Medical Center - Chicago (Westside Hospital)
Chicago, Illinois, 60612, United States
CCOP - Central Illinois
Decatur, Illinois, 62526, United States
Veterans Affairs Medical Center - Hines
Hines, Illinois, 60141, United States
Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois, 60153-5500, United States
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, 66160-7353, United States
CCOP - Wichita
Wichita, Kansas, 67214-3882, United States
Veterans Affairs Medical Center - Wichita
Wichita, Kansas, 67218, United States
Veterans Affairs Medical Center - Lexington
Lexington, Kentucky, 40502-2236, United States
Markey Cancer Center at University of Kentucky Chandler Medical Center
Lexington, Kentucky, 40536-0084, United States
MBCCOP - LSU Health Sciences Center
New Orleans, Louisiana, 70112, United States
Tulane Cancer Center at Tulane University Hospital and Clinic
New Orleans, Louisiana, 70112, United States
Veterans Affairs Medical Center - New Orleans
New Orleans, Louisiana, 70112, United States
Veterans Affairs Medical Center - Shreveport
Shreveport, Louisiana, 71101-4295, United States
Louisiana State University Health Sciences Center - Shreveport
Shreveport, Louisiana, 71130-3932, United States
Cancer Research Center at Boston Medical Center
Boston, Massachusetts, 02118, United States
CCOP - Michigan Cancer Research Consortium
Ann Arbor, Michigan, 48106, United States
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109-0948, United States
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, 48201-1379, United States
Veterans Affairs Medical Center - Detroit
Detroit, Michigan, 48201-1932, United States
Josephine Ford Cancer Center at Henry Ford Health System
Detroit, Michigan, 48202, United States
CCOP - Grand Rapids
Grand Rapids, Michigan, 49503, United States
CCOP - Beaumont
Royal Oak, Michigan, 48073-6769, United States
Providence Cancer Institute at Providence Hospital - Southfield
Southfield, Michigan, 48075, United States
University of Mississippi Medical Center
Jackson, Mississippi, 39216-4505, United States
Veterans Affairs Medical Center - Jackson
Jackson, Mississippi, 39216, United States
CCOP - Kansas City
Kansas City, Missouri, 64131, United States
CCOP - Cancer Research for the Ozarks
Springfield, Missouri, 65807, United States
St. Louis University Hospital Cancer Center
St Louis, Missouri, 63110, United States
CCOP - St. Louis-Cape Girardeau
St Louis, Missouri, 63141, United States
CCOP - Montana Cancer Consortium
Billings, Montana, 59101, United States
Veterans Affairs Medical Center - Albuquerque
Albuquerque, New Mexico, 87108-5138, United States
MBCCOP - University of New Mexico HSC
Albuquerque, New Mexico, 87131, United States
NYU School of Medicine's Kaplan Comprehensive Cancer Center
New York, New York, 10016, United States
Herbert Irving Comprehensive Cancer Center at Columbia University
New York, New York, 10032, United States
James P. Wilmot Cancer Center at University of Rochester Medical Center
Rochester, New York, 14642, United States
CCOP - Southeast Cancer Control Consortium
Goldsboro, North Carolina, 27534-9479, United States
Veterans Affairs Medical Center - Cincinnati
Cincinnati, Ohio, 45220-2288, United States
Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio, 45267-0501, United States
Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, 44195-9001, United States
CCOP - Columbus
Columbus, Ohio, 43206, United States
Veterans Affairs Medical Center - Dayton
Dayton, Ohio, 45428-1002, United States
CCOP - Dayton
Dayton, Ohio, 45429, United States
Oklahoma University Medical Center
Oklahoma City, Oklahoma, 73104, United States
Cancer Institute at Oregon Health and Science University
Portland, Oregon, 97201-3098, United States
Veterans Affairs Medical Center - Portland
Portland, Oregon, 97207, United States
CCOP - Columbia River Oncology Program
Portland, Oregon, 97225, United States
Veterans Affairs Medical Center - Charleston
Charleston, South Carolina, 29401-5799, United States
Hollings Cancer Center at Medical University of South Carolina
Charleston, South Carolina, 29425, United States
CCOP - Greenville
Greenville, South Carolina, 29615, United States
CCOP - Upstate Carolina
Spartanburg, South Carolina, 29303, United States
University of Tennessee Cancer Institute at Methodist Central Hospital
Memphis, Tennessee, 38104, United States
Veterans Affairs Medical Center - Memphis
Memphis, Tennessee, 38104, United States
Harrington Cancer Center
Amarillo, Texas, 79106, United States
Veterans Affairs Medical Center - Amarillo
Amarillo, Texas, 79106, United States
Brooke Army Medical Center
Fort Sam Houston, Texas, 78234-6200, United States
University of Texas Medical Branch
Galveston, Texas, 77555-0565, United States
University of Texas - MD Anderson Cancer Center
Houston, Texas, 77030-4095, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229-3900, United States
Veterans Affairs Medical Center - San Antonio (Murphy)
San Antonio, Texas, 78229, United States
Veterans Affairs Medical Center - Temple
Temple, Texas, 76504, United States
CCOP - Scott and White Hospital
Temple, Texas, 76508, United States
Huntsman Cancer Institute
Salt Lake City, Utah, 84112-5550, United States
Veterans Affairs Medical Center - Salt Lake City
Salt Lake City, Utah, 84148, United States
CCOP - Virginia Mason Research Center
Seattle, Washington, 98101, United States
Veterans Affairs Medical Center - Seattle
Seattle, Washington, 98108, United States
Puget Sound Oncology Consortium
Seattle, Washington, 98109, United States
CCOP - Northwest
Tacoma, Washington, 98405-0986, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Heinz-Josef Lenz, MD
University of Southern California
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 12, 2002
First Posted
January 27, 2003
Study Start
February 1, 2003
Primary Completion
June 1, 2007
Study Completion
June 1, 2007
Last Updated
January 3, 2013
Record last verified: 2013-01